Evidence map›Paper›PMID 33816370›Full record

ReviewMedical journal of the Islamic Republic of Iran2020

Efficacy and safety of chloroquine and hydroxychloroquine for COVID-19: A comprehensive evidence synthesis of clinical, animal, and in vitro studies.

Farzaneh Barzkar, Mitra Ranjbar, Amir-Babak Sioofy-Khojine, Mohammadamin Khajehazad, Roya Vesal Azad, Yousef Moradi, Hamid Reza Baradaran

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medical journal of the Islamic Republic of Iran, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Farzaneh BarzkarEndocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Mitra RanjbarDepartment of Infectious Diseases, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Amir-Babak Sioofy-KhojineDepartment of Virology, Faculty of Medicine and Life Sciences, PL 100, 33014 University of Tampere, Tampere, Finland.
Mohammadamin KhajehazadDepartment of Infectious Diseases, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Roya Vesal AzadSchool of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Yousef MoradiSocial Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Hamid Reza BaradaranEndocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
Iran University of Medical Sciences · IRKurdistan University of Medical Sciences · IRTampere University · FIUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19EfficacyHydroxychloroquineSafetySystematic review

Identifiers

PMID33816370
PMCPMC8004577
OpenAlexW3118532008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.